P Vague
Publications by Year
Research Areas
Diabetes and associated disorders, Diabetes Management and Research, Diet and metabolism studies, Pancreatic function and diabetes, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis(1991)573 cited
- → Clearance of Tissue Plasminogen Activator (TPA) and TPA/Plasminogen Activator Inhibitor Type 1 (PAI-1) Complex(1997)243 cited
- → Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.(1989)203 cited
- → Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin(2004)179 cited
- → Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects(1987)166 cited
- → Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women(1989)128 cited
- → Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.(1998)122 cited
- → Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS)(2003)78 cited
- → Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.(1993)70 cited
- → Increased PA-Inhibitor Levels in the Postoperative Period – No Cause-Effect Relation with Increased Cortisol(1985)66 cited